The obesity paradox: body mass index and outcomes in patients with heart failure.

By J. Curtis, J. Selter, Yongfei Wang, S. Rathore, I. Jovin, F. Jadbabaie, M. Kosiborod, E. Portnay, Seth I. Sokol, F. Bader and 1 more. Archives of Internal Medicine, 2005

841 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism

View Paper: https://www.semanticscholar.org/paper/23de6573f93b7e4fd1386e9ae6131589512eae58

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. T. Horwich
2. E. Dale Abel
3. S. Malnick
4. H. Knobler
5. G. Fonarow
6. M. Salive

In Endocrinology, Diabetes and Metabolism

1. S. Malnick
2. H. Knobler
3. P. Sherliker
4. M. Salive

Citations in the corpus

• Cardiac remodeling in obesity. (2008, background): “In another cohort of outpatients with established heart failure, higher BMIs were associated with lower mortality risk (65).”
• Epidemiology and risk profile of heart failure (2010, background): “Among those with established HF, however, there is evidence that obesity is associated with improved outcomes”
• Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies (2009, positive): “…substantial eff ects of obesity on disability, quality of life, or non-fatal disease (eg, osteoarthritis, obstructive sleep apnoea); or the positive eff ects of some types of adiposity on prognosis after some chronic disorders (eg, heart failure, 34 respiratory disease 35 ) have already developed.”
• The medical complications of obesity. (2006, background): “Elevated BMI, however, appears to be associated with an improved survival in patients with congestive heart failure (CHF).(56) In the large Digitalis Intervention Group trial, patients who were overweight (BMI 25.”